Wright Medical Group N.V. (NASDAQ:WMGI)‘s stock had its “buy” rating reaffirmed by Royal Bank Of Canada in a research note issued to investors on Thursday. They currently have a $30.00 target price on the medical device company’s stock. Royal Bank Of Canada’s target price indicates a potential upside of 14.46% from the company’s current price.

Several other equities analysts have also recently issued reports on WMGI. BMO Capital Markets lowered their price target on Wright Medical Group N.V. from $34.00 to $31.00 and set an “outperform” rating on the stock in a research report on Thursday. Needham & Company LLC reiterated a “hold” rating on shares of Wright Medical Group N.V. in a research report on Thursday. Barclays PLC lowered their price target on Wright Medical Group N.V. from $33.00 to $30.00 and set an “overweight” rating on the stock in a research report on Thursday. BidaskClub upgraded Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $33.00 price target on shares of Wright Medical Group N.V. in a research report on Friday, August 4th. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $31.50.

Wright Medical Group N.V. (NASDAQ:WMGI) last announced its earnings results on Wednesday, November 1st. The medical device company reported ($0.16) earnings per share for the quarter, meeting the consensus estimate of ($0.16). Wright Medical Group N.V. had a negative return on equity of 6.22% and a negative net margin of 36.04%. The firm had revenue of $170.50 million for the quarter, compared to the consensus estimate of $173.50 million. During the same quarter in the previous year, the business earned ($0.19) EPS. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/11/02/royal-bank-of-canada-reiterates-buy-rating-for-wright-medical-group-n-v-wmgi.html.

Several hedge funds have recently modified their holdings of the company. FMR LLC grew its holdings in shares of Wright Medical Group N.V. by 5.7% during the second quarter. FMR LLC now owns 15,644,806 shares of the medical device company’s stock valued at $430,075,000 after buying an additional 845,909 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Wright Medical Group N.V. by 1.8% during the second quarter. Vanguard Group Inc. now owns 8,232,880 shares of the medical device company’s stock valued at $226,321,000 after buying an additional 145,930 shares in the last quarter. Fisher Asset Management LLC grew its holdings in shares of Wright Medical Group N.V. by 20.9% during the third quarter. Fisher Asset Management LLC now owns 2,890,789 shares of the medical device company’s stock valued at $74,785,000 after buying an additional 500,583 shares in the last quarter. Capital Research Global Investors grew its holdings in shares of Wright Medical Group N.V. by 60.9% during the second quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock valued at $76,285,000 after buying an additional 1,050,000 shares in the last quarter. Finally, Palo Alto Investors LLC grew its holdings in shares of Wright Medical Group N.V. by 1.8% during the second quarter. Palo Alto Investors LLC now owns 2,676,393 shares of the medical device company’s stock valued at $73,574,000 after buying an additional 48,200 shares in the last quarter.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.